About
Develops a bacterial outer membrane vesicle (OMV) platform engineered for precision immunization and for use as targeted drug delivery vehicles. The company focuses on leveraging OMVs to create tailored vaccine and delivery solutions.
Explore Nexus BioSolutions's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.